EN DE
Watch Redex Protech Limited for free: we tell you when fair value or trend changes.
Data-driven stock valuation

Redex Protech Limited (523650) fair value: what the stock is really worth

As of Nov 17, 2026: fair value (intrinsic value) of Redex Protech Limited stock ₹62.71, price ₹38.46, upside +63.1%, quality 30 out of 100. Rating: strongly undervalued. Calculated from audited financials with 9 of our 26 valuation models and 37 quality factors, updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Services IN

RP Redex Protech Limited logo Thin data Nov 15, 2026

Redex Protech Limited

523650 · BSE

Cheap (39% below fair value), but weak company and price moving sideways: meets 1 of 3 rules.

Get notified free when this changes
Fair value ₹62.71 · Strongly undervalued 
Highly profitable · 47.4% net margin (TTM) 
Even on cautious assumptions the value is 22% above the price (₹47.03). 
Price moving sideways (no uptrend) 
Mixed Growth (revenue 5y +166.8 %/yr in INR) 
Moderate debt 
Mixed vs. peers (5/10) 
Wide moat 71/100 · thin data
Changed on Oct 20: ₹38.07 → ₹62.71 
Quality 30/100 
Negative free cash flow 
Thin data 
⚠ Dilution
Watch Redex Protech Limited for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

₹67.07 ₹6.10 Fair Value ₹62.71 Jun 2021 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 15, 2026.

How to read this chart

60‑month range ₹6.10 – ₹67.07 · fair‑value band ₹47.03 – ₹78.39 · the ₹38.46 price screens below the ₹62.71 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 15, 2026.

Follow Redex Protech in your weekly email

Every Wednesday you see whether Redex Protech is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Redex Protech Limited engages in the fire extinguisher equipment business in India. It offers smoke alarms, smoke detectors, and related services, as well as extinguisher refilling and labor services. The company was incorporated in 1991 and is based in Ahmedabad, India.

Stock analysis

Redex Protech Limited (523650) currently trades at ₹38.46, while our model-based Fair Value estimate is ₹62.71, implying the stock looks roughly 39% undervalued today.

Show more

Valuation

Bull case: the Growth Earnings group reads highest at a median of ₹133.17 per share, and 6 of the 9 models we run sit above the ₹38.46 price.

Bear case: the Asset-Based group reads lowest at ₹13.69, and 3 of the 9 models stay below the price. Data coverage for this calculation is low.

Scenario range: ₹47.03 (bear) to ₹78.39 (bull), the price of ₹38.46 sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 30/100 (below-average quality), in the Services sector.

Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.

Redex Protech Limited reported revenue of ₹13.8M in FY2026 versus ₹197K in FY2022, a compound +189.3%/yr. Reported net income was ₹17.7M in FY2026, compounding −32.6%/yr from FY2022.

Key figures

Market cap ₹54.4M (≈ $580K) · P/E ratio 13.9 · P/S ratio 6.56 · EPS (TTM) ₹0.5940 · Net margin 47.4% · Return on assets (EBIT) −3.6% (5-year average) · Operating margin 65.5% · Revenue (TTM) ₹8.5M.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 71 out of 100 (low confidence).

What moves the price

The share trades about 23% below its 52-week high and 42% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Services peers we cover trades at −13% fair-value upside, at 63%, 523650 screens cheaper than that median.

Fair Value models

Bear ₹47.03 Fair Value ₹62.71 Bull ₹78.39
Price ₹38.46 · Upside +63.1%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2026 figures (about 8 months old). Earnings retained since then (₹0.3759 per share) are deliberately not added. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
Residual Income ₹17.47 ₹19.62 ₹24.97 68
Growth-Adj P/E ₹93.22 ₹133.17 ₹173.12 65
P/E Multiple ₹55.33 ₹73.78 ₹92.22 63
All 9 models by family
Earnings-Based
Graham-Dodd ₹17.92 ₹124.96 ₹175.36 61
Lynch FV ₹64.56 ₹92.22 ₹119.89 59
PEG = 1.0 ₹64.56 ₹92.22 ₹119.89 55
Multiples
P/E Multiple ₹55.33 ₹73.78 ₹92.22 63
P/S Multiple ₹8.47 ₹11.29 ₹14.12 58
P/B Multiple ₹91.93 ₹122.57 ₹153.21 55
Asset-Based
NCAV (Graham) ₹10.21 ₹13.69 ₹20.43 54
Economic Profit
Residual Income ₹17.47 ₹19.62 ₹24.97 68
Growth Earnings
Growth-Adj P/E ₹93.22 ₹133.17 ₹173.12 65

The fair value above starts from this blend and is adjusted for dilution from new shares.

Open the full fair value analysis →

Quality Score breakdown

Overall quality 30/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 38
How much profit the company makes from its sales and capital
Quality Growth 89
Are margins and returns getting better?
Cashflow 0
Do the profits arrive as real cash?
Financial strength 6
Debt, balance sheet and risk of trouble
Investment 31
Does it invest with discipline instead of growing at any price?
Low Volatility 50
How calm the share price moves, does not count
Price momentum 41
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 38
Distance to the 52-week high, does not count
New shares 0
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 49/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+166.8%
Start year 2021 (pandemic). Over 10 years: +16.0% a year
Revenue growth 12 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+13.1%
What shareholders gained per year (last 5 years), in INR ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Measured in INR: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
−38.7%
Earnings growth per share plus dividend.
Earnings per share, growth per year−38.7%
Dividend (yield on the price)0.0%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.−38.7% vs 18.8%, slowing
Profit margin 2021 to 2026 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.−2,897% → −113%
Pace: the 5-year rate starts in 2021 (pandemic)

Watch 523650, get fair value alerts →

Compare Redex Protech Limited with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its sector: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median. (Industry “Industrial Equipment Wholesale” was too small, so the broader sector is used.)Information Technology · 3980 stocks

Beats the sector median on 5/9 measures
A mixed picture versus its sector peers.
Valuation
Quality Score 30 · Bottom 25%
Fair Value upside +63.1% · Top 25%
Profitability
Return on assets 2.8% · Above median
Net margin (12 months) 47.4% · Top 25%
Operating margin (12 months) 65.5% · Top 25%
Growth and dividend
Revenue growth (quarter YoY) −67.4% · Bottom 25%
Dividend yield (12 months) 0.0% · Bottom 25%
Balance sheet
Debt / equity 1.48× · Highest 25%

Valuation Multiplesvs Information Technology median · lower = cheaper

P/E (12 months) 13.9× · Cheaper than median

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)100 · sector 18
FUTURE (revenue growth)0 · sector 60
PAST (return on equity)0 · sector 23
HEALTH (low debt)26 · sector 97
DIVIDEND (yield)0 · sector 28

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Industrial Equipment Wholesale stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Archies Limited 532212 ₹10.92 ₹21.06 +93% vs 523650
Inducto Steels Limited 532001 ₹71.78 ₹100.97 +41% vs 523650
CHLOGIST CHLOGIST ₹7.10 ₹8.66 +22% vs 523650
Shalimar Productions Limited 512499 ₹0.2300 ₹0.2019 −12% vs 523650
Oriental Veneer Products Limited 531859 ₹119.30 ₹103.59 −13% vs 523650
Sinclairs Hotels Limited 523023 ₹73.00 ₹55.95 −23% vs 523650
SANCTRN SANCTRN ₹710.00 ₹512.31 −28% vs 523650
DLTNCBL DLTNCBL ₹674.10 ₹477.05 −29% vs 523650
VADILENT VADILENT ₹9,380 ₹1,575 −83% vs 523650
GVFILM GVFILM ₹0.3000 ₹0.0400 −87% vs 523650

Explore undervalued stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Redex Protech Limited: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "Redex Protech Limited Fair Value". https://www.fairvalue-calculator.com/stock/523650

Frequently asked questions

Is Redex Protech Limited (523650) overvalued or undervalued?
As of Nov 15, 2026, our model estimates a fair value of ₹62.71 versus a price of ₹38.46, about +63% upside (undervalued).
What is the fair value of 523650?
Our model-based fair value for Redex Protech Limited is ₹62.71 (as of Nov 15, 2026), built from audited fundamentals. The current price: ₹38.46.
What is the quality score of 523650?
Redex Protech Limited has a Quality Score of 30/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Redex Protech Limited (523650)?
Our model-based price target is the fair value of ₹62.71 (as of Nov 15, 2026) from 9 valuation models. Cautious scenario ₹47.03, optimistic scenario ₹78.39. It is a calculation from audited fundamentals, not an analyst target.
What is the Redex Protech Limited stock forecast for 2026?
Our models put fair value at ₹62.71, about +63% upside versus a price of ₹38.46 (undervalued). Cautious scenario ₹47.03, optimistic scenario ₹78.39. The calculation is refreshed regularly with new filings.
What is the revenue of Redex Protech Limited (523650)?
Redex Protech Limited reported trailing-twelve-month revenue of about ₹8.5M (latest available figure, as of Nov 15, 2026).
What is the intrinsic value of Redex Protech Limited (523650)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Redex Protech Limited it is ₹62.71 per share (as of Nov 15, 2026), against a price of ₹38.46. It is the blended result of 9 valuation models in 5 families (Earnings-Based, Multiples, Asset-Based, Economic Profit, Growth Earnings).
Is Redex Protech Limited stock overvalued or undervalued in 2026?
As of Nov 15, 2026, 523650 trades below its calculated fair value: price ₹38.46, fair value ₹62.71, a gap of about +63% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 523650?
No. The price is what the market pays today (₹38.46); the fair value is what the company's own numbers justify (₹62.71). For Redex Protech Limited the two are ₹24.25 per share apart. That gap is exactly why we show both numbers side by side.
How much is Redex Protech Limited worth?
The market values Redex Protech Limited at about ₹54.4M (market capitalisation, as of Nov 15, 2026). Per share that is ₹38.46; our models calculate a fair value of ₹62.71 per share.
What do the bullish and bearish scenarios say about 523650?
Our models span a range for Redex Protech Limited: cautious scenario ₹47.03, base ₹62.71, optimistic ₹78.39 per share (as of Nov 15, 2026, price ₹38.46). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of 523650?
Redex Protech Limited trades at a price-to-earnings ratio of 13.9 (as of Nov 15, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of ₹62.71 is built from several models across several years. Median P/E at fiscal year-end, 5 fiscal years (2016 to 2026), reported earnings: 31.7.
How solid is the balance sheet of Redex Protech Limited (523650)?
Balance-sheet figures for Redex Protech Limited (as of Nov 15, 2026): debt of 1.48 per unit of equity. They feed the Quality Score of 30/100, which measures business quality independently of the share price.
How far is 523650 from its 52-week high?
Redex Protech Limited trades at ₹38.46, about 23% below its 52-week high of ₹50.13 and 42% above the low of ₹27.10 (as of Nov 17, 2026). Distance from the high says nothing about value: that is what the fair value of ₹62.71 is for.
Which stocks are comparable to Redex Protech Limited?
From the same area (Services) we also value DLTNCBL, VADILENT, Oriental Veneer Products Limited, SANCTRN, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Redex Protech Limited stock attractive at the current price?
The data as of Nov 15, 2026: price ₹38.46, calculated fair value ₹62.71 (+63%), Quality Score 30/100, from 9 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 523650 calculated?
We run Redex Protech Limited through 9 models from 5 families: Earnings-Based, Multiples, Asset-Based, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of ₹62.71 builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.6% above its aggregate fair value. Redex Protech Limited currently trades 39% below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Redex Protech Limited (523650)?
The closing price on Nov 17, 2026 was ₹38.46. Our model-based fair value is ₹62.71, about +63% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Redex Protech Limited right now?
The large discount to fair value meets weak quality (30/100). That raises the risk this is a value trap rather than a bargain. The price is below even our cautious bear case (₹47.03). The market is more pessimistic than our downside scenario. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.

Key figures of Redex Protech Limited

How large is the market capitalisation of Redex Protech Limited (523650)?
The market capitalisation of Redex Protech Limited is ₹54.4M (≈ $580K). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Redex Protech Limited (523650)?
The price-to-sales ratio of Redex Protech Limited is 6.56 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Redex Protech Limited (523650)?
Earnings per share at Redex Protech Limited are ₹0.5940 (price ÷ EPS = P/E 13.9). Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Redex Protech Limited (523650)?
The net margin of Redex Protech Limited is 47.4% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the EBIT return on assets of Redex Protech Limited (523650)?
On an EBIT basis the return on assets of Redex Protech Limited is −3.6% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Redex Protech Limited (523650)?
The operating margin of Redex Protech Limited is 65.5% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Redex Protech Limited (523650)?
Revenue at Redex Protech Limited is down 67.4% versus a year earlier (3y avg +471%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Redex Protech Limited (523650)?
Earnings per share at Redex Protech Limited are down 16.7% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Redex Protech Limited (523650) generate?
The free cash flow of Redex Protech Limited is −₹318M (fiscal year 2026). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Redex Protech Limited (523650) carry?
The net debt of Redex Protech Limited is ₹368M (fiscal year 2026). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch Redex Protech Limited in the live analysis

One click puts Redex Protech Limited on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.